January 30, 2019
A Study of Tivozanib (AV-951), an Oral VEGF Receptor Tyrosine Kinase Inhibitor, in the Treatment of Renal Cell Carcinoma
Read More
January 30, 2019
Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta®
Read More
December 10, 2018
Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis
Read More
X